Kayne Anderson Capital Advisors LP Takes $5.30 Million Position in Danaher Corporation $DHR

Key Points

• Kayne Anderson Capital Advisors acquired 7,362 Danaher shares worth approximately $5.3 million, while institutional investors collectively own 79.05% of the company.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $228.91, despite several firms recently lowering their targets.
• Danaher reported quarterly EPS of $1.94, beating estimates of $1.85, while revenue reached $6.26 billion and increased 5.5% year over year.

Kayne Anderson Capital Advisors LP acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 7,362 shares of the conglomerate's stock, valued at approximately $5,301,000.

A number of other hedge funds have also recently bought and sold shares of DHR. BlackRock Inc. acquired a new position in shares of Danaher during the second quarter valued at $10,492,520,000. Norges Bank acquired a new position in Danaher during the 4th quarter valued at about $2,177,106,000. Generation Investment Management LLP bought a new position in shares of Danaher in the 2nd quarter valued at about $1,287,949,000. Flossbach Von Storch SE acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $747,260,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of Danaher during the second quarter worth approximately $712,875,000. 79.05% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

DHR has been the topic of a number of analyst reports. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 price target on the stock. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a $240.00 price target on shares of Danaher in a research report on Wednesday, July 22nd. HSBC reduced their price target on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research report on Wednesday, June 3rd. Wall Street Zen cut Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, April 25th. Finally, Stifel Nicolaus lowered their target price on Danaher from $260.00 to $220.00 and set a "buy" rating for the company in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Trading Up 1.6%

Shares of NYSE:DHR opened at $219.42 on Friday. The stock has a market capitalization of $154.25 billion, a PE ratio of 38.97, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company's 50-day moving average price is $195.80 and its two-hundred day moving average price is $192.61. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business's quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.77 earnings per share. On average, equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source